Skip to main content
Clinical Trials/EUCTR2017-004429-34-BE
EUCTR2017-004429-34-BE
Active, not recruiting
Phase 1

Histological and Transcriptional Changes caused by Endometrial Flushing with Lipiodol: A Cross Over Study. - Changes at the level of the endometrium caused by Lipiodol intrauterine flush.

Z Brussel0 sites20 target enrollmentJanuary 11, 2018

Overview

Phase
Phase 1
Intervention
Not specified
Conditions
Female subfertility
Sponsor
Z Brussel
Enrollment
20
Status
Active, not recruiting
Last Updated
7 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
January 11, 2018
End Date
TBD
Last Updated
7 years ago
Study Type
Interventional clinical trial of medicinal product

Investigators

Sponsor
Z Brussel

Eligibility Criteria

Inclusion Criteria

  • ?Women aged \=18 and \<36 years
  • ?Regular cycle (25\-35 days)
  • ?Signed informed consent
  • ?Participants can be included only once in the trial
  • ?Contraceptive: barrier method only.
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1\.2 Adults (18\-64 years) yes
  • F.1\.2\.1 Number of subjects for this age range 20
  • F.1\.3 Elderly (\>\=65 years) no

Exclusion Criteria

  • ?known iodine allergy
  • ?Body mass index ? 30 or \=18\.5
  • ?Previous diagnosis of PCO (\>12 antral follicles
  • in one ovary, Rotterdam criteria 2003\)
  • ?Previous diagnosis of endometriosis, uterine malformations or intrauterine pathologies (submucosal fibroids, endometrial polyps, and intrauterine adhesions)
  • ?Systemic diseases such as thyroid dysfunction
  • ?Received hormonal treatments in the previous 3 months
  • ?Breast\-feeding or pregnancy within the last 6 months
  • ?Intrauterine devices (IUD)
  • ?History of recurrent miscarriage

Outcomes

Primary Outcomes

Not specified

Similar Trials